These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10566003)

  • 21. Analysis of in vivo immunosuppressive and in vitro interaction with constitutive heat shock protein 70 activity of LF08-0299 (Tresperimus) and analogues.
    Komesli S; Dumas C; Dutartre P
    Int J Immunopharmacol; 1999 May; 21(5):349-58. PubMed ID: 10408631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterotopic rat intestinal transplantation: effect of cyclosporine and RS-61443 on graft-vs-host disease and rejection.
    D'Alessandro AM; Rankin MA
    Transplant Proc; 1994 Jun; 26(3):1611-2. PubMed ID: 8030056
    [No Abstract]   [Full Text] [Related]  

  • 23. Current trends in immunosuppression.
    González Posada JM
    Nefrologia; 2006; 26 Suppl 2():3-8. PubMed ID: 17937629
    [No Abstract]   [Full Text] [Related]  

  • 24. Deoxyspergualin--a different and intriguing immunosuppressant.
    Tufveson G; Gannedahl G
    Transplant Proc; 1994 Oct; 26(5):3029-39. PubMed ID: 7940954
    [No Abstract]   [Full Text] [Related]  

  • 25. Leflunomide immunosuppression in rat small intestinal transplantation.
    Foster PF; Xiao F; Kociss K; Chong AS; Sankary HN; McChesney L; Cohn S; Williams JW
    Transplant Proc; 1994 Jun; 26(3):1599-600. PubMed ID: 8030053
    [No Abstract]   [Full Text] [Related]  

  • 26. Sirolimus, the first mTOR inhibitor.
    Sánchez-Plumed JA; González Molina M; Alonso A; Arias M
    Nefrologia; 2006; 26 Suppl 2():21-32. PubMed ID: 17937632
    [No Abstract]   [Full Text] [Related]  

  • 27. New goals to be achieved in clinical transplantation.
    Manez R
    Drug News Perspect; 2006 Oct; 19(8):509-12. PubMed ID: 17160153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Basic immunosuppressive drugs outside solid organ transplantation.
    Braun F; Behrend M
    Expert Opin Investig Drugs; 2006 Mar; 15(3):267-91. PubMed ID: 16503764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of tresperimus on ex vivo expansion of CD34+CD38(-)-enriched cord blood cells.
    el Marsafy S; Dutartre P; Gluckman E
    Haematologia (Budap); 2002; 32(4):327-36. PubMed ID: 12803107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FK 506--an investigational immunosuppressant.
    Med Lett Drugs Ther; 1991 Oct; 33(854):94. PubMed ID: 1716722
    [No Abstract]   [Full Text] [Related]  

  • 31. Novel pharmacotherapeutic approaches to prevention and treatment of GVHD.
    Jacobsohn DA; Vogelsang GB
    Drugs; 2002; 62(6):879-89. PubMed ID: 11929336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Graft rejections and their treatments].
    Remiszewski P; Wiatr E
    Pneumonol Alergol Pol; 2005; 73(1):94-9. PubMed ID: 16539191
    [No Abstract]   [Full Text] [Related]  

  • 33. Advances in immunosuppression for kidney transplantation: new strategies for preserving kidney function and reducing cardiovascular risk.
    Bestard O; Campistol JM; Morales JM; Sánchez-Fructuoso A; Cabello M; Cabello V; Pallardó LM; Grinyó JM
    Nefrologia; 2012 May; 32(3):374-84. PubMed ID: 22535159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Belatacept, a new original molecule, immunosuppressive, in organ transplantation].
    Beaudreuil S; Durrbach A; Kriaa F; Charpentier B
    Med Sci (Paris); 2006 Apr; 22(4):354-5. PubMed ID: 16597399
    [No Abstract]   [Full Text] [Related]  

  • 35. RS-61443 prevents graft-versus-host disease but not rejection in allogeneic rat small bowel transplants.
    Sonnino RE
    Transplant Proc; 1992 Jun; 24(3):1190. PubMed ID: 1604581
    [No Abstract]   [Full Text] [Related]  

  • 36. [Immunosuppressors].
    Sánchez-Fructuoso AI
    Nefrologia; 2008; 28 Suppl 5():21-5. PubMed ID: 18847416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [I Guidelines of the Brazilian Cardiology Society for Heart Transplantation: IV. Rejection].
    Bacal F; de Lima MG; Manrique R; Higuchi Mde L; Brofman P; Tenório D; de Souza JD; de Carvalho AC; de Souza MM
    Arq Bras Cardiol; 1999 Sep; 73 Suppl 5():21-6. PubMed ID: 10883479
    [No Abstract]   [Full Text] [Related]  

  • 38. Donor pretreatment with rapamycin delays rejection following intestinal allotransplantation.
    He G; Zhong R; Zhang Z; Garcia B; Black R; Duff J; Grant D
    Transplant Proc; 1992 Jun; 24(3):1178. PubMed ID: 1604577
    [No Abstract]   [Full Text] [Related]  

  • 39. Antirejection strategy in small bowel transplantation.
    Wood RF
    Transplant Proc; 1996 Oct; 28(5):2491-3. PubMed ID: 8907918
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunosuppressive power and limitations of FK 506 for prevention and treatment of graft-vs-host disease after small bowel transplantation.
    Platz KP; Mueller AR; Langrehr JM; Neuhaus P; Schraut WH
    Transplant Proc; 1996 Oct; 28(5):2523-4. PubMed ID: 8907933
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.